AAAAAA

   
Results: 1-8 |
Results: 8
RENAL CLEARANCE, TISSUE DISTRIBUTION, AND CA-125 RESPONSES IN A PHASE-I TRIAL OF SURAMIN
Authors: HUTSON PR TUTSCH KD RAGO R ARZOOMANIAN R ALBERTI D POMPLUN M CHURCH D MARNOCHA R CHENG AL KEHRLI N WILDING G
Citation: Pr. Hutson et al., RENAL CLEARANCE, TISSUE DISTRIBUTION, AND CA-125 RESPONSES IN A PHASE-I TRIAL OF SURAMIN, Clinical cancer research, 4(6), 1998, pp. 1429-1436
A PHASE-I STUDY OF AG3340, A MATRIX METALLOPROTEASE (MMP) INHIBITOR, IN PATIENTS HAVING ADVANCED CANCER
Authors: HANDE K WILDING G RIPPLE G FRY J ARZOOMANIAN R DIXON M YUEN G COLLIER M
Citation: K. Hande et al., A PHASE-I STUDY OF AG3340, A MATRIX METALLOPROTEASE (MMP) INHIBITOR, IN PATIENTS HAVING ADVANCED CANCER, Annals of oncology, 9, 1998, pp. 279-279
PHASE-I TRIALS OF PERILLYL ALCOHOL ADMINISTERED ORALLY ON A CONTINUOUS DAILY BASIS
Authors: BAILEY H RIPPLE G GOULD M ARZOOMANIAN R ALBERTI D FEIERABEND C SIMON K MORGAN K TUTSCH K POMPLUN M WAHAMAKI A MARNOCHA R WILDING G
Citation: H. Bailey et al., PHASE-I TRIALS OF PERILLYL ALCOHOL ADMINISTERED ORALLY ON A CONTINUOUS DAILY BASIS, Annals of oncology, 9, 1998, pp. 409-409
CONTINUOUS 28 DAY IODODEOXYURIDINE (IUDR) INFUSION AND HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (HART) FOR MALIGNANT GLIOMA - A PHASE-I CLINICAL AND THYMIDINE REPLACEMENT STUDY
Authors: SCHULZ CA MEHTA MP ROBINS HI BADIE B ARZOOMANIAN R SIMON K ALBERTI D FEIERABEND C KUNUGI KA WILDING G KINSELLA TJ
Citation: Ca. Schulz et al., CONTINUOUS 28 DAY IODODEOXYURIDINE (IUDR) INFUSION AND HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (HART) FOR MALIGNANT GLIOMA - A PHASE-I CLINICAL AND THYMIDINE REPLACEMENT STUDY, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 139-139
A PHASE-I STUDY OF 5-FLUOROURACIL, LEUCOVORIN AND LEVAMISOLE
Authors: CLEARY JF ARZOOMANIAN R ALBERTI D FEIERABEND C STORER B WITT P CARBONE P WILDING G
Citation: Jf. Cleary et al., A PHASE-I STUDY OF 5-FLUOROURACIL, LEUCOVORIN AND LEVAMISOLE, Cancer chemotherapy and pharmacology, 39(4), 1997, pp. 300-306
PHASE-I TRIAL OF 3-HOUR INFUSION OF PACLITAXEL WITH OR WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH ADVANCED CANCER
Authors: SCHILLER JH STORER B TUTSCH K ARZOOMANIAN R ALBERTI D FEIERABEND C SPRIGGS D
Citation: Jh. Schiller et al., PHASE-I TRIAL OF 3-HOUR INFUSION OF PACLITAXEL WITH OR WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH ADVANCED CANCER, Journal of clinical oncology, 12(2), 1994, pp. 241-248
A PHASE-I TRIAL OF 3-HOUR INFUSIONS OF PACLITAXEL (TAXOL) WITH OR WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR
Authors: SCHILLER JH STORER B TUTSCH K ARZOOMANIAN R ALBERTI D FEIERABEND C SPRIGGS D
Citation: Jh. Schiller et al., A PHASE-I TRIAL OF 3-HOUR INFUSIONS OF PACLITAXEL (TAXOL) WITH OR WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR, Seminars in oncology, 21(5), 1994, pp. 9-14
PHASE-I TRIAL OF MITOXANTRONE AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES
Authors: SCHILLER JH STORER B ARZOOMANIAN R TUTSCH K ALBERTI D SPRIGGS D
Citation: Jh. Schiller et al., PHASE-I TRIAL OF MITOXANTRONE AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES, Investigational new drugs, 11(4), 1993, pp. 291-300
Risultati: 1-8 |